Fine mapping of susceptibility genes by Lewontin's linkage disequilibrium measure with application to Alzheimer's disease
- Author:
- No author available
- Journal Title:
- CHINESE MEDICAL JOURNAL
- Issue:
- 8
- DOI:
- No doi available
- Key Word:
- linkage disequilibrium mapping;complex trait;phenocopies;penetrance;mutation;selection;susceptibility genes
Abstract： Objectives To formulate an equation for fine mapping of disease loci under complex conditions and determine the marker-disease distance in a specific case using this equation. Methods Lewontin's linkage disequilibrium (LD) measure D' was used to formulate an equation for mapping disease genes in the presence of phenocopies, locus heterogeneity, gene-gene and gene-environment interactions, incomplete penetrance, uncertain liability and threshold, incomplete initial LD, natural selection, recurrent mutation, high disease allele frequency and unknown mode of inheritance. This equation was then used to determine the distance between a marker (ε4 within the apolipoprotein E gene, APOE) and Alzheimer's disease (AD) loci using published data.Results An equation was formulated for mapping disease genes under the above conditions. If these conditions are present but ignored, then recombination fraction θ between marker and disease loci will be either overestimated or estimated with little bias. Therefore, an upper limit of θ can be obtained. AD has been found to be associated with the marker allele ε4 in Africans, Asians, and Caucasians. This suggests that the AD-ε4 allelic LD predates the divergence of peoples occurring 100·!000 years ago. With the age of AD-ε4 allelic LD so estimated, the maximal distance was calculated to be 23.2 kb (mean 5.8 kb).Conclusions (1) A method is developed for LD mapping of susceptibility genes. (2) A mutation within the APOE gene itself, among others, is responsible for the susceptibility to AD, which is supported by recent evidence from studies using transgenic mice.
- [1]Gambaro G,Anglani F,D'Angelo A.Association studies of genetic polymorphisms and complex disease.[J].2000,355(9200).
- [2]A M, Goate.Molecular genetics of Alzheimer's disease.[J].1997,52 Suppl 2.
- [3]D B, Carr,A, Goate,D, Phil,etc.Current concepts in the pathogenesis of Alzheimer's disease.[J].1997,103.
- [4]Hesse C,Aevarsson O,Landahl S,etc.A population study of apoE genotype at the age of 85: relation to dementia, cerebrovascular disease, and mortality.[J].1998,64(1).
- [5]B. DEVLIN,NEIL RISCH.A Comparison of Linkage Disequilibrium Measures for Fine-Scale Mapping[J].1995,29(2).
- [6]W J, Strittmatter,A M, Saunders,D, Schmechel,etc.Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.[J].1993,90.
- [7]S L, Zegura.The initial peopling of the Americas: an overview from the perspective of physical anthropology.[J].1984,8(1-2).
- [8]Evans Denis A..Apolipoprotein E\u03f54 and Incidence of Alzheimer Disease in a Community Population of Older Persons[J].1997.
- [9]Newton E. Morton.Significance Levels in Complex Inheritance[J].1998,62(3).
- [10]Myers R. H.,Schaefer E. J.,Wilson P.W.F.,etc.Apolipoprotein E element 4 association with dementia in a population-based study: The Framingham Study[J].1996.
- [11]Morton NE,Collins A.Tests and estimates of allelic association in complex inheritance.[J].1998,95(19).
- [12]Xavier Jeunemaitre,Florent Soubrier,Yuri V. Kotelevtsev,etc.Molecular basis of human hypertension: Role of angiotensinogen[J].1992,71(1).
- [13]Farrer L. A..Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium[J].1997.
- [14]Lin C,Wyss Coray-T,Akeefe H,etc.Dominant negative effects of apolipoprotein E4 revealed in transgenic models of neurodegenerative disease.[J].2000,97(2).
- [15]Pratt JH,Bloem LJ,Manatunga AK,etc.The serum angiotensinogen concentration and variants of the angiotensinogen gene in white and black children.[J].1995,95(3).
- [16]Fleet, J. C.,Harris, S. S.,Wood, R. J.,etc.Rapid Publication. The BsmI Vitamin D Receptor Restriction Fragment Length Polymorphism (BB) Predicts Low Bone Density in Premenopausal Black and White Women[J].1995,10(6).
- [17]S A, Tishkoff,E, Dietzsch,W, Speed,etc.Global patterns of linkage disequilibrium at the CD4 locus and modern human origins.[J].1996,271.
- [18]B L, Plassman,J C, Breitner.Recent advances in the genetics of Alzheimer's disease and vascular dementia with an emphasis on gene-environment interactions.[J].1996,44(10).
- [19]Recker RR,Gong G,Fong N,etc.The association of bone mineral density with vitamin D receptor gene polymorphisms.[J].1999,9(1).
- [20]A. Cissé,M. Chauffert,D. Chevenne,etc.Distribution of HLA-DQA1 and -DQB1 alleles and DQA1-DQB1 genotypes among Senegalese patients with insulin-dependent diabetes mellitus[J].1996,47(4).
- [21]C. LONJOU,A. COLLINE,N. E. MORTON.Allelic association between marker loci[J].1999,96(16).
- [22]Gura T..GENETICS: Can SNPs Deliver on Susceptibility Genes?[J].2001.
- [23]David M. Holtzman MD,Anne M. Fagan PhD,Brian Mackey BS,etc.Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer's disease model[J].2000,47(6).